{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:31:24Z","timestamp":1787315484796,"version":"build-2736575974"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Aortic aneurysms, including abdominal aortic aneurysms (AAAs), is the second most prevalent aortic disease and represents an important cause of death worldwide. AAA is a permanent dilation of the aorta on its infrarenal portion, pathologically associated with oxidative stress, proteolysis, vascular smooth muscle cell loss, immune-inflammation, and extracellular matrix remodeling and degradation. Most epidemiological studies have shown a potential protective role of diabetes mellitus (DM) on the prevalence and incidence of AAA. The effect of DM on AAA might be explained mainly by two factors: hyperglycemia [or other DM-related factors such as insulin resistance (IR)] and\/or by the effect of prescribed DM drugs, which may have a direct or indirect effect on the formation and progression of AAAs. However, recent studies further support that the protective role of DM in AAA may be attributable to antidiabetic therapies (i.e.: metformin or SGLT-2 inhibitors). This review summarizes current literature on the relationship between DM and the incidence, progression, and rupture of AAAs, and discusses the potential cellular and molecular pathways that may be involved in its vascular effects. Besides, we provide a summary of current antidiabetic therapies which use could be beneficial for AAA.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1112430","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:22:32Z","timestamp":1679541752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?"],"prefix":"10.3389","volume":"10","author":[{"given":"Bel\u00e9n","family":"Picatoste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Cerro-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Blanco-Colio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Mart\u00edn-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCULATIONAHA.116.022305","article-title":"Outcome of the Swedish nationwide abdominal aortic aneurysm screening program","volume":"134","author":"Wanhainen","year":"2016","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC)","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/cvr\/cvq337","article-title":"Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans","volume":"90","author":"Michel","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.arteri.2018.10.002","article-title":"Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets","volume":"31","author":"Torres-Fonseca","year":"2019","journal-title":"Clin E Investig En Arterioscler Publicacion of Soc Espanola Arterioscler"},{"key":"B5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biomedicines10010094","article-title":"AAA Revisited: a comprehensive review of risk factors, management, and hallmarks of pathogenesis","volume":"10","author":"Kessler","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/bjs.8698","article-title":"Explaining the decrease in mortality from abdominal aortic aneurysm rupture","volume":"99","author":"Anjum","year":"2012","journal-title":"Br J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.117.028259","article-title":"A population-based study of abdominal aortic aneurysm treatment in Finland 2000 to 2014","volume":"136","author":"Laine","year":"2017","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/jech-2018-210644","article-title":"Understanding abdominal aortic aneurysm epidemiology: socioeconomic position affects outcome","volume":"72","author":"Zommorodi","year":"2018","journal-title":"J Epidemiol Community Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.annepidem.2017.12.003","article-title":"Diabetes-related factors and abdominal aortic aneurysm events: the atherosclerotic risk in communities study","volume":"28","author":"Kubota","year":"2018","journal-title":"Ann Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jvs.2009.07.001","article-title":"SVS Practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary","volume":"50","author":"Chaikof","year":"2009","journal-title":"J Vasc Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2337\/diaspect.21.3.177","article-title":"Best practices for lowering the risk of cardiovascular disease in diabetes","volume":"21","author":"Triplitt","year":"2008","journal-title":"Diabetes Spectr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","article-title":"Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention","volume":"13","author":"Tan","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.arteri.2018.01.002","article-title":"Diabetes mellitus as a protective factor of abdominal aortic aneurysm: possible mechanisms","volume":"30","author":"Climent","year":"2018","journal-title":"Clin E Investig En Arterioscler Publicacion of Soc Espanola Arterioscler"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/cvr\/cvy174","article-title":"Diabetes and aortic aneurysm: current state of the art","volume":"114","author":"Raffort","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jdiacomp.2015.08.011","article-title":"Abdominal aortic aneurysms and diabetes mellitus","volume":"29","author":"Pafili","year":"2015","journal-title":"J Diabetes Complications"},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejvs.2005.08.015","article-title":"Review of prevalence and outcome of vascular disease in patients with diabetes mellitus","volume":"31","author":"Weiss","year":"2006","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1479164116651389","article-title":"ALICE (All-Literature investigation of cardiovascular evidence) group. Negative association of diabetes with rupture of abdominal aortic aneurysm","volume":"13","author":"Takagi","year":"2016","journal-title":"Diab Vasc Dis Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-015-0216-1","article-title":"National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003-2012)","volume":"14","author":"Lopez-de-Andr\u00e9s","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S0140-6736(15)60401-9","article-title":"Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"385","author":"Dinesh Shah","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijcard.2016.07.016","article-title":"Association between diabetes and prevalence and growth rate of abdominal aortic aneurysms: a meta-analysis","volume":"221","author":"Xiong","year":"2016","journal-title":"Int J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejvs.2013.12.007","article-title":"Diabetes and abdominal aortic aneurysms","volume":"47","author":"De Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/eurheartj\/ehm557","article-title":"Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions","volume":"29","author":"Golledge","year":"2008","journal-title":"Eur Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/ATVBAHA.116.308874","article-title":"Glycated hemoglobin is associated with the growth rate of abdominal aortic aneurysms: a substudy from the VIVA (viborg vascular) randomized screening trial","volume":"37","author":"Kristensen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jvs.2021.10.019","article-title":"The effect of diabetes on abdominal aortic aneurysm growth over 2 years","volume":"75","author":"Nordness","year":"2022","journal-title":"J Vasc Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1538574413505921","article-title":"Diabetes mellitus and aortic aneurysm rupture: a favorable association?","volume":"48","author":"Theivacumar","year":"2014","journal-title":"Vasc Endovascular Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1038\/s41598-021-98893-x","article-title":"Nationwide study in France investigating the impact of diabetes on mortality in patients undergoing abdominal aortic aneurysm repair","volume":"11","author":"Raffort","year":"2021","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1583\/04-1260MR.1","article-title":"Influence of diabetes mellitus on the endovascular treatment of abdominal aortic aneurysms","volume":"12","author":"Leurs","year":"2005","journal-title":"J Endovasc Ther Off J Int Soc Endovasc Spec"},{"key":"B29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jvs.2019.01.063","article-title":"Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without type 2 diabetes","volume":"71","author":"Taimour","year":"2020","journal-title":"J Vasc Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jss.2013.04.025","article-title":"Diabetes mellitus is not associated with major morbidity following open abdominal aortic aneurysm repair","volume":"184","author":"Hughes","year":"2013","journal-title":"J Surg Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.avsg.2019.01.011","article-title":"Long-term survival and cardiovascular morbidity after elective open aortic aneurysm repair in patients with and without type 2 diabetes: a nationwide propensity-adjusted analysis","volume":"59","author":"Zarrouk","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/1358863X19870243","article-title":"Survival, cardiovascular morbidity, and reinterventions after elective endovascular aortic aneurysm repair in patients with and without diabetes: a nationwide propensity-adjusted analysis","volume":"24","author":"Taimour","year":"2019","journal-title":"Vasc Med Lond Engl"},{"key":"B33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.surg.2010.05.014","article-title":"Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease","volume":"148","author":"Dua","year":"2010","journal-title":"Surgery"},{"key":"B34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jvs.2010.05.086","article-title":"Hyperglycemia limits experimental aortic aneurysm progression","volume":"52","author":"Miyama","year":"2010","journal-title":"J Vasc Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00125-009-1555-9","article-title":"Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis","volume":"53","author":"Pham","year":"2010","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1681\/ASN.2013010060","article-title":"Genetic deletion of cell division autoantigen 1 retards diabetes-associated renal injury","volume":"24","author":"Chai","year":"2013","journal-title":"J Am Soc Nephrol JASN"},{"key":"B37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/db17-0134","article-title":"Diabetes reduces severity of aortic aneurysms depending on the presence of cell division autoantigen 1 (CDA1)","volume":"67","author":"Li","year":"2018","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.104.523357","article-title":"Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy","volume":"112","author":"Dai","year":"2005","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI38136","article-title":"TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice","volume":"120","author":"Wang","year":"2010","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0153811","DOI":"10.1371\/journal.pone.0153811","article-title":"TGF-\u03b2 Neutralization enhances AngII-induced aortic rupture and aneurysm in both thoracic and abdominal regions","volume":"11","author":"Chen","year":"2016","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejvs.2021.10.030","article-title":"Treatment with the prolyl hydroxylase inhibitor JNJ promotes abdominal aortic aneurysm progression in diabetic mice","volume":"63","author":"Guo","year":"2022","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ejvs.2021.10.038","article-title":"Genetic predisposition to diabetes and abdominal aortic aneurysm: a two stage Mendelian randomisation study","volume":"63","author":"Morris","year":"2022","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cpf.12667","article-title":"Increased arterial stiffness in males with abdominal aortic aneurysm","volume":"41","author":"\u00c5str\u00f6m Malm","year":"2021","journal-title":"Clin Physiol Funct Imaging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6306542","DOI":"10.1155\/2018\/6306542","article-title":"Endothelium as a potential target for treatment of abdominal aortic aneurysm","volume":"2018","author":"Sun","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/biom12040509","article-title":"Endothelial dysfunction in the pathogenesis of abdominal aortic aneurysm","volume":"12","author":"DeRoo","year":"2022","journal-title":"Biomolecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.5551\/jat.50930","article-title":"Impact of diabetes Mellitus on the aortic wall changes as atherosclerosis progresses: aortic dilatation and calcification","volume":"27","author":"Iwakawa","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"B48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2337\/dbi20-0030","article-title":"Epigenetic mechanisms in diabetic vascular complications and metabolic memory: the 2020 edwin bierman award lecture","volume":"70","author":"Natarajan","year":"2021","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s00125-015-3600-1","article-title":"50 Years forward: mechanisms of hyperglycaemia-driven diabetic complications","volume":"58","author":"Russell","year":"2015","journal-title":"Diabetologia"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3086167","DOI":"10.1155\/2018\/3086167","article-title":"Complications of diabetes 2017","volume":"2018","author":"Papatheodorou","year":"2018","journal-title":"J Diabetes Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fendo.2019.00640","article-title":"Molecular mechanisms of glucose fluctuations on diabetic complications","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"96568","DOI":"10.18632\/oncotarget.19951","article-title":"Activation of Nrf2-mediated anti-oxidant genes by antrodin C prevents hyperglycemia-induced senescence and apoptosis in human endothelial cells","volume":"8","author":"Senthil","year":"2017","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3390\/ijms23052879","article-title":"Hyperglycemia promotes endothelial cell senescence through AQR\/PLAU signaling axis","volume":"23","author":"Wan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-018-0263-x","article-title":"Exosomes from hyperglycemia-stimulated vascular endothelial cells contain versican that regulate calcification\/senescence in vascular smooth muscle cells","volume":"9","author":"Li","year":"2019","journal-title":"Cell Biosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.biocel.2010.02.009","article-title":"Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by \u03b23 integrin signaling","volume":"42","author":"Panchatcharam","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1253\/circj.70.1076","article-title":"Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase","volume":"70","author":"Kuki","year":"2006","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"B57","doi-asserted-by":"publisher","first-page":"665412","DOI":"10.3389\/fcell.2021.665412","article-title":"Role of hyperglycemia in the senescence of mesenchymal stem cells","volume":"9","author":"Yin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1074\/jbc.RA118.005398","article-title":"Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1\u2013mediated p53\/KLF4 complex stabilization","volume":"294","author":"Xi","year":"2019","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ejvs.2006.11.011","article-title":"Reduced aortic wall stress in diabetes mellitus","volume":"33","author":"Astrand","year":"2007","journal-title":"Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/CIRCGENETICS.115.001165","article-title":"Quantitative proteome analysis reveals increased content of basement membrane proteins in arteries from patients with type 2 diabetes Mellitus and lower levels among metformin users","volume":"8","author":"Preil","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12933-021-01375-7","article-title":"Basement membrane proteins in various arterial beds from individuals with and without type 2 diabetes mellitus: a proteome study","volume":"20","author":"Steffensen","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"12903","DOI":"10.1038\/s41598-021-92303-y","article-title":"Basement membrane collagen IV deficiency promotes abdominal aortic aneurysm formation","volume":"11","author":"Steffensen","year":"2021","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jvs.2016.04.028","article-title":"A potential role for glycated cross-links in abdominal aortic aneurysm disease","volume":"65","author":"Koole","year":"2017","journal-title":"J Vasc Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.2337\/dc20-0909","article-title":"Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes","volume":"43","author":"Ranjan","year":"2020","journal-title":"Diabetes Care"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2337\/dc14-0199","article-title":"Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial","volume":"37","author":"Hirakawa","year":"2014","journal-title":"Diabetes Care"},{"key":"B67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","article-title":"Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)","volume":"61","author":"Zinman","year":"2018","journal-title":"Diabetologia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2337\/dc18-0548","article-title":"Glycemic variation and cardiovascular risk in the veterans affairs diabetes trial","volume":"41","author":"Zhou","year":"2018","journal-title":"Diabetes Care"},{"key":"B69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc18-1430","article-title":"Visit-to-Visit glycemic variability and risks of cardiovascular events and all-cause mortality: the ALLHAT study","volume":"42","author":"Echouffo-Tcheugui","year":"2019","journal-title":"Diabetes Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2337\/dc19-2589","article-title":"Prognostic significance of long-term HbA1c variability for all-cause mortality in the ACCORD trial","volume":"43","author":"Sheng","year":"2020","journal-title":"Diabetes Care"},{"key":"B71","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12933-020-01147-9","article-title":"Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial","volume":"19","author":"Ceriello","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/ATVBAHA.109.192658","article-title":"Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation","volume":"29","author":"Police","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/ATVBAHA.107.160382","article-title":"Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice","volume":"28","author":"Henriques","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3400\/avd.ra.17-00130","article-title":"Pathological implication of adipocytes in AAA development and the rupture","volume":"11","author":"Kugo","year":"2018","journal-title":"Ann Vasc Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3521649","DOI":"10.1155\/2017\/3521649","article-title":"Associations of diabetes and obesity with risk of abdominal aortic aneurysm in men","volume":"2017","author":"Wang","year":"2017","journal-title":"J Obes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/bjs.8983","article-title":"Obesity and abdominal aortic aneurysm","volume":"100","author":"Stackelberg","year":"2013","journal-title":"Br J Surg"},{"key":"B77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehm582","article-title":"Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm","volume":"29","author":"Wassink","year":"2008","journal-title":"Eur Heart J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2003.12.033","article-title":"Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm","volume":"173","author":"Gorter","year":"2004","journal-title":"Atherosclerosis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.asjsur.2021.05.046","article-title":"The relation between metabolic syndrome and aspects of abdominal aortic aneurysm","volume":"45","author":"Lee","year":"2022","journal-title":"Asian J Surg"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jvs.2015.12.056","article-title":"Inflammatory cells, ceramides, and expression of proteases in perivascular adipose tissue adjacent to human abdominal aortic aneurysms","volume":"65","author":"Folkesson","year":"2017","journal-title":"J Vasc Surg"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2014.05.923","article-title":"Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice","volume":"235","author":"Yoshida","year":"2014","journal-title":"Atherosclerosis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"31414","DOI":"10.1038\/srep31414","article-title":"Elevated adiponectin levels suppress perivascular and aortic inflammation and prevent AngII-induced advanced abdominal aortic aneurysms","volume":"6","author":"W\u00e5gs\u00e4ter","year":"2016","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"618434","DOI":"10.3389\/fendo.2021.618434","article-title":"Role of adipokines and perivascular adipose tissue in abdominal aortic aneurysm: a systematic review and meta-analysis of animal and human observational studies","volume":"12","author":"Thanigaimani","year":"2021","journal-title":"Front Endocrinol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.117.09512","article-title":"Perivascular adipose tissue angiotensin II type 1 receptor promotes vascular inflammation and aneurysm formation","volume":"70","author":"Sakaue","year":"2017","journal-title":"Hypertens Dallas Tex"},{"key":"B86","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.3390\/ijms23116048","article-title":"Angiotensin II inhibits insulin receptor signaling in adipose cells","volume":"23","author":"Gutierrez-Rodelo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: mechanisms of injury and protective factors","volume":"17","author":"Rask-Madsen","year":"2013","journal-title":"Cell Metab"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1172\/JCI118709","article-title":"Obesity\/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance","volume":"97","author":"Steinberg","year":"1996","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","first-page":"030702","DOI":"10.11613\/BM.2018.030702","article-title":"Association of abdominal aortic aneurysm diameter with insulin resistance index","volume":"28","author":"Lareyre","year":"2018","journal-title":"Biochem Medica"},{"key":"B91","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2010.03.013","article-title":"Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice","volume":"11","author":"Rask-Madsen","year":"2010","journal-title":"Cell Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1172\/JCI15211","article-title":"The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance","volume":"111","author":"Vicent","year":"2003","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/metabo12020128","article-title":"Diabetes-Induced changes in macrophage biology might lead to reduced risk for abdominal aortic aneurysm development","volume":"12","author":"Chinetti","year":"2022","journal-title":"Metabolites"},{"key":"B94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/(SICI)1099-0844(199603)14:1%3C33::AID-CBF637%3E3.3.CO;2-U","article-title":"The effect of insulin on macrophage metabolism and function","volume":"14","author":"Costa Rosa","year":"1996","journal-title":"Cell Biochem Funct"},{"key":"B95","doi-asserted-by":"publisher","first-page":"32531","DOI":"10.1074\/jbc.M009894200","article-title":"Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway","volume":"276","author":"Iida","year":"2001","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2337\/db08-0520","article-title":"Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress","volume":"57","author":"Senokuchi","year":"2008","journal-title":"Diabetes"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.2337\/db09-0232","article-title":"Foxo1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages","volume":"58","author":"Su","year":"2009","journal-title":"Diabetes"},{"key":"B98","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/hq0302.105272","article-title":"Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway","volume":"22","author":"Iida","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B99","article-title":"Oral hypoglycemic medications","volume-title":"Statpearls","author":"Ganesan","year":"2022"},{"key":"B100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2337\/cd22-as01","article-title":"Standards of medical care in diabetes\u20142022 abridged for primary care providers","volume":"40","year":"2022","journal-title":"Clin Diabetes"},{"key":"B101","year":""},{"key":"B102","article-title":"Pathogenesis of type 2 diabetes Mellitus","volume-title":"Endotext","author":"Solis-Herrera","year":"2000"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"B106","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet Lond Engl"},{"key":"B107","doi-asserted-by":"publisher","first-page":"59","DOI":"10.17219\/acem\/142026","article-title":"Metformin protects against abdominal aortic aneurysm by Atg7-induced autophagy","volume":"31","author":"Guo","year":"2022","journal-title":"Adv Clin Exp Med Off Organ Wroclaw Med Univ"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"B110","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jvs.2016.02.020","article-title":"Metformin treatment status and abdominal aortic aneurysm disease progression","volume":"64","author":"Fujimura","year":"2016","journal-title":"J Vasc Surg"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30887","article-title":"Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor","author":"Phadwal","year":"","journal-title":"J Cell Physiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jvs.2018.06.194","article-title":"Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. Veteran population","volume":"69","author":"Itoga","year":"2019","journal-title":"J Vasc Surg"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jvs.2019.08.270","article-title":"Relationship between metformin and abdominal aortic aneurysm","volume":"71","author":"Raffort","year":"2020","journal-title":"J Vasc Surg"},{"key":"B114","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000513465","article-title":"Metformin inhibits abdominal aortic aneurysm formation through the activation of the AMPK\/mTOR signaling pathway","volume":"58","author":"He","year":"2021","journal-title":"J Vasc Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin prescription associated with reduced abdominal aortic aneurysm growth rate and reduced chemokine expression in a Swedish cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/bjs.10587","article-title":"Association between metformin prescription and growth rates of abdominal aortic aneurysms","volume":"104","author":"Golledge","year":"2017","journal-title":"Br J Surg"},{"key":"B117","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e0268451","DOI":"10.1371\/journal.pone.0268451","article-title":"Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium","volume":"17","author":"Li","year":"2022","journal-title":"PloS One"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jdiacomp.2016.04.018","article-title":"Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase","volume":"30","author":"An","year":"2016","journal-title":"J Diabetes Complications"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3892\/mmr.2012.753","article-title":"Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells","volume":"5","author":"Esfahanian","year":"2012","journal-title":"Mol Med Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.721213","article-title":"The protective effect of metformin on abdominal aortic aneurysm: a systematic review and meta-analysis","author":"Yuan","year":"2021","journal-title":"Front Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1186\/s13063-021-05915-0","article-title":"Protocol for the metformin aneurysm trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm","volume":"22","author":"Golledge","year":"2021","journal-title":"Trials"},{"key":"B123","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejvs.2020.11.048","article-title":"The metformin for abdominal aortic aneurysm growth inhibition (MAAAGI) trial","volume":"61","author":"Wanhainen","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B124","year":""},{"key":"B125","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11748-015-0576-1","article-title":"PPAR-\u03b3 agonist attenuates inflammation in aortic aneurysm patients","volume":"63","author":"Motoki","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B126","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/sj.bjp.0707452","article-title":"Thiazolidinediones: effects on insulin resistance and the cardiovascular system","volume":"153","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2012.07.034","article-title":"Rosiglitazone negatively regulates c-jun N-terminal kinase and toll-like receptor 4 proinflammatory signalling during initiation of experimental aortic aneurysms","volume":"225","author":"Pirianov","year":"2012","journal-title":"Atherosclerosis"},{"key":"B128","article-title":"Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes","volume-title":"Endotext","author":"Feingold","year":"2000"},{"key":"B129","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2009.10.027","article-title":"Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm","volume":"210","author":"Golledge","year":"2010","journal-title":"Atherosclerosis"},{"key":"B130","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1161\/CIRCULATIONAHA.109.852467","article-title":"Rosiglitazone reduces the development and rupture of experimental aortic aneurysms","volume":"119","author":"Jones","year":"2009","journal-title":"Circulation"},{"key":"B131","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-016-0447-9","article-title":"Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case\u2013control analysis","volume":"15","author":"Hsu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00125-018-4669-0","article-title":"The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure","volume":"61","author":"Thomas","year":"2018","journal-title":"Diabetologia"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e0146337","DOI":"10.1371\/journal.pone.0146337","article-title":"The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice","volume":"11","author":"Honda","year":"2016","journal-title":"PloS One"},{"key":"B134","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s40261-016-0383-1","article-title":"Effectiveness of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, as a second-line treatment for non-alcoholic fatty liver disease patients with type 2 diabetes Mellitus who do not respond to incretin-based therapies including glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors","volume":"36","author":"Ohki","year":"2016","journal-title":"Clin Drug Investig"},{"key":"B135","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/21623945.2017.1413516","article-title":"Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: focus on fat browning and macrophage polarization","volume":"7","author":"Xu","year":"2018","journal-title":"Adipocyte"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e0179960","DOI":"10.1371\/journal.pone.0179960","article-title":"Effects of canagliflozin on weight loss in high-fat diet-induced obese mice","volume":"12","author":"Ji","year":"2017","journal-title":"PloS One"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B138","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","article-title":"Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"B139","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00125-016-4158-2","article-title":"The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -\/- mice fed a western diet","volume":"60","author":"Han","year":"2017","journal-title":"Diabetologia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"E1704","DOI":"10.3390\/ijms18081704","article-title":"The SGLT2 inhibitor luseogliflozin rapidly normalizes aortic mRNA levels of inflammation-related but not lipid-metabolism-related genes and suppresses atherosclerosis in diabetic ApoE KO mice","volume":"18","author":"Nakatsu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/ATVBAHA.119.312659","article-title":"SGLT-2 (Sodium-Glucose cotransporter 2) inhibition reduces ang II (angiotensin II)-induced dissecting abdominal aortic aneurysm in ApoE (apolipoprotein E) knockout mice","volume":"39","author":"Ortega","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"8502059","DOI":"10.1155\/2022\/8502059","article-title":"Dapagliflozin ameliorates the formation and progression of experimental abdominal aortic aneurysms by reducing aortic inflammation in mice","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1161\/ATVBAHA.116.307530","article-title":"Vitamin D receptor activation reduces angiotensin-II-induced dissecting abdominal aortic aneurysm in apolipoprotein E-knockout mice","volume":"36","author":"Martorell","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/cvr\/cvs298","article-title":"Importance of endothelial NF-\u03baB signalling in vascular remodelling and aortic aneurysm formation","volume":"97","author":"Saito","year":"2013","journal-title":"Cardiovasc Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biochi.2018.06.026","article-title":"Glucagon-Like peptide-1: a new therapeutic target to treat abdominal aortic aneurysm?","volume":"152","author":"Raffort","year":"2018","journal-title":"Biochimie"},{"key":"B146","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1358863X211034574","article-title":"The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: a systematic review","volume":"27","author":"Ngetich","year":"2022","journal-title":"Vasc Med Lond Engl"},{"key":"B147","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/biomedicines9060697","article-title":"Syndecan-1 expression is increased in the aortic wall of patients with type 2 diabetes but is unrelated to elevated fasting plasma glucagon-like peptide-1","volume":"9","author":"Ntika","year":"2021","journal-title":"Biomedicines"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00595-015-1287-z","article-title":"Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats","volume":"46","author":"Yu","year":"2016","journal-title":"Surg Today"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e0121077","DOI":"10.1371\/journal.pone.0121077","article-title":"Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice","volume":"10","author":"Lu","year":"2015","journal-title":"PloS One"},{"key":"B150","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijcard.2012.01.011","article-title":"Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury","volume":"167","author":"Chinda","year":"2013","journal-title":"Int J Cardiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"P603","DOI":"10.1093\/eurheartj\/eht307.P603","article-title":"Vildagliptin, a dipeptidyl peptidase-4 inhibitor, ameliorates the development of CaCl2-induced abdominal aortic aneurysm in mice via anti-inflammatory effects","volume":"34","author":"Noda","year":"2013","journal-title":"Eur Heart J"},{"key":"B152","doi-asserted-by":"publisher","first-page":"698","DOI":"10.5551\/jat.42481","article-title":"Suppression of abdominal aortic aneurysm formation in mice by teneligliptin, a dipeptidyl peptidase-4 inhibitor","volume":"25","author":"Takahara","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jvs.2013.04.048","article-title":"Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats","volume":"59","author":"Bao","year":"2014","journal-title":"J Vasc Surg"},{"key":"B154","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1161\/atvb.37.suppl_1.101","article-title":"Abstract 101: dipeptidylpeptidase-iv inhibition using MK626 attenuates BAPB\/AT2 induced murine aneurysm","volume":"37","author":"Byrne","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B155","year":""},{"key":"B156","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrcardio.2017.52","article-title":"Monocytes and macrophages in abdominal aortic aneurysm","volume":"14","author":"Raffort","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4049\/jimmunol.0803164","article-title":"Blocking TNF-alpha attenuates aneurysm formation in a murine model","volume":"183","author":"Xiong","year":"2009","journal-title":"J Immunol Baltim Md"},{"key":"B158","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"Longo","year":"2002","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1112430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T03:22:38Z","timestamp":1679541758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1112430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":158,"alternative-id":["10.3389\/fcvm.2023.1112430"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1112430","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"article-number":"1112430"}}